SCHEMBL25489464

SCHEMBL25489464

CC(C)(C)NCc1cnc(CC(C)(C)NCc2cnc(C#N)s2)o1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25488481 0.82 SLC8A1 (0.34) —
SCHEMBL10204766 0.62 L3MBTL1 (0.46) —
SCHEMBL25489463 0.62 CYP2C19 (0.35) —
SCHEMBL7995338 0.60 — —
SCHEMBL18641483 0.60 — —
SCHEMBL129913 0.60 — —
SCHEMBL18641382 0.60 — —
SCHEMBL10862830 0.59 MAOB (0.33) —
SCHEMBL21325047 0.58 NPC1 (0.33) —
SCHEMBL24777619 0.56 CDK2 (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230146675-A1 PYRIMIDO[5,4-d]PYRIMIDINE DERIVATIVES AS ENT INHIBITORS FOR THE TREATMENT OF CANCERS, AND COMBINATION THEREOF WITH ADENOSINE RECEPTOR ANTAGONISTS iTeos Belgium SA (BE) 2023-05-11 — — US disclosed
Send feedback